Characteristics and Outcomes Among Adults Aged ≥60 Years Hospitalized with Laboratory-Confirmed Respiratory Syncytial Virus — RSV-NET, 12 States, July 2022

Characteristics and Outcomes Among Adults Aged ≥60 Years Hospitalized with Laboratory-Confirmed Respiratory Syncytial Virus — RSV-NET, 12 States, July 2022–June 2023

Published:2023-10-06 Issue:40 Volume:72 Page:1075-1082
ISSN:0149-2195
Container-title:MMWR. Morbidity and Mortality Weekly Report
language:
Short-container-title:MMWR Morb. Mortal. Wkly. Rep.

Author:

Havers Fiona P.,Whitaker Michael,Melgar Michael,Chatwani Bhoomija,Chai Shua J.,Alden Nisha B.,Meek James,Openo Kyle P.,Ryan Patricia A.,Kim Sue,Lynfield Ruth,Shaw Yomei P.,Barney Grant,Tesini Brenda L.,Sutton Melissa,Talbot H. Keipp,Olsen Kristen P.,Patton Monica E.,Kirley Pam Daily,Austin Elizabeth,Kim Daewi,Surell Chandler,Monroe Maya,Leegwater Lauren,Mumm Erica,Bleecker Molly,Rowe Adam,Popham Kevin,Novak Arilene,Schaffner William,Staten Holly, ,

Publisher

Centers for Disease Control MMWR Office

Subject

Health Information Management,Health, Toxicology and Mutagenesis,General Medicine,Health (social science),Epidemiology

Reference9 articles.

1. Use of respiratory syncytial virus vaccines in older adults: recommendations of the Advisory Committee on Immunization Practices—United States, 2023.;Melgar;MMWR Morb Mortal Wkly Rep,2023

2. Seasonality of respiratory syncytial virus—United States, 2017–2023.;Hamid;MMWR Morb Mortal Wkly Rep,2023

3. Developing a sampling methodology for timely reporting of population-based COVID-19-associated hospitalization surveillance in the United States, COVID-NET 2020–2021.;O’Halloran;Influenza Other Respir Viruses,2023

4. Rates of respiratory syncytial virus (RSV)–associated hospitalization among adults with congestive heart failure—United States, 2015–2017.;Kujawski;PLoS One,2022

5. Incidence of respiratory syncytial virus infection among hospitalized adults, 2017–2020.;Branche;Clin Infect Dis,2022

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of vaccinating adults aged 60 years and older against respiratory syncytial virus;Vaccine;2024-10

2. RSV Vaccine Effectiveness Against Hospitalization Among US Adults 60 Years and Older;JAMA;2024-09-04

3. Adult Respiratory Syncytial Virus Infection: Defining Incidence, Risk Factors for Hospitalization, and Poor Outcomes, a Regional Cohort Study, 2016–2022;Pathogens;2024-08-31

4. Systematic Review of the Efficacy and Safety of RSV‐Specific Monoclonal Antibodies and Antivirals in Development;Reviews in Medical Virology;2024-08-29

5. Respiratory syncytial virus: challenges in diagnosis and impact on the elderly: Recommendations from a multidisciplinary panel;Human Vaccines & Immunotherapeutics;2024-08-19